Johnson & Johnson's long-term prospects are promising due to strong drug pipeline developments and significant R&D ...

A federal judge ordered a Johnson & Johnson unit on Friday to pay the U.S. government $1.64 billion after a jury found it ...

A unit of medical group Johnson & Johnson (JNJ) has been ordered to pay $1.64 billion for illegally promoting the HIV drugs Prezista and ...

Johnson & Johnson has been in a holding pattern, posting a small return of 0.7% while floating around $163.19.

Johnson & Johnson (NYSE:JNJ – Get Free Report) has received a consensus rating of “Moderate Buy” from the eighteen research ...

Johnson & Johnson (JNJ) is one of the stocks most watched by Zacks.com visitors lately. So, it might be a good idea to review ...

We recently published a list of Jim Cramer Focused On These 9 Stocks Recently. In this article, we are going to take a look ...

Johnson & Johnson said it is increasing U.S investments to more than $55 billion over the next four years, boosting spending ...

Johnson & Johnson (NYSE: JNJ), has broken ground on a $2 billion pharmaceutical manufacturing facility in Wilson, about 50 ...

Companies in the Healthcare sector have received a lot of coverage today as analysts weigh in on Johnson & Johnson (JNJ – Research ...

Johnson & Johnson MedTech says Dualto is the first and only surgical energy system to be made available in double ...

Johnson & Johnson (NYSE:JNJ) experienced an 11% price increase over the last quarter. This movement coincided with several ...